Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Replication of associations between GWAS SNPs and melanoma risk in the Population Architecture Using Genomics and Epidemiology (PAGE) Study.

Kocarnik JM, Park SL, Han J, Dumitrescu L, Cheng I, Wilkens LR, Schumacher FR, Kolonel L, Carlson CS, Crawford DC, Goodloe RJ, Dilks H, Baker P, Richardson D, Ambite JL, Song F, Quresh AA, Zhang M, Duggan D, Hutter C, Hindorff LA, Bush WS, Kooperberg C, Le Marchand L, Peters U.

J Invest Dermatol. 2014 Jul;134(7):2049-2052. doi: 10.1038/jid.2014.53. Epub 2014 Jan 30. No abstract available. Erratum in: J Invest Dermatol. 2014 Nov;134(11):2852.

2.

Pleiotropic and sex-specific effects of cancer GWAS SNPs on melanoma risk in the population architecture using genomics and epidemiology (PAGE) study.

Kocarnik JM, Park SL, Han J, Dumitrescu L, Cheng I, Wilkens LR, Schumacher FR, Kolonel L, Carlson CS, Crawford DC, Goodloe RJ, Dilks HH, Baker P, Richardson D, Matise TC, Ambite JL, Song F, Qureshi AA, Zhang M, Duggan D, Hutter C, Hindorff L, Bush WS, Kooperberg C, Le Marchand L, Peters U.

PLoS One. 2015 Mar 19;10(3):e0120491. doi: 10.1371/journal.pone.0120491. eCollection 2015.

3.

The association of host and genetic melanoma risk factors with Breslow thickness in the Western Australian Melanoma Health Study.

Cadby G, Ward SV, Cole JM, Moses EK, Millward M, Palmer LJ.

Br J Dermatol. 2014 Apr;170(4):851-7. doi: 10.1111/bjd.12829.

PMID:
24405011
4.

Genome-wide association studies in melanoma: off to a good start.

Kim HK, Chanock SJ.

Pigment Cell Melanoma Res. 2012 Mar;25(2):231-3. doi: 10.1111/j.1755-148X.2012.00981.x. Epub 2012 Feb 9. No abstract available.

PMID:
22268896
5.

Genetic variants in telomere-maintaining genes and skin cancer risk.

Nan H, Qureshi AA, Prescott J, De Vivo I, Han J.

Hum Genet. 2011 Mar;129(3):247-53. doi: 10.1007/s00439-010-0921-5. Epub 2010 Nov 30.

6.

Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma.

Chatzinasiou F, Lill CM, Kypreou K, Stefanaki I, Nicolaou V, Spyrou G, Evangelou E, Roehr JT, Kodela E, Katsambas A, Tsao H, Ioannidis JP, Bertram L, Stratigos AJ.

J Natl Cancer Inst. 2011 Aug 17;103(16):1227-35. doi: 10.1093/jnci/djr219. Epub 2011 Jun 21. Review.

7.

Variants at the 9p21 locus and melanoma risk.

Maccioni L, Rachakonda PS, Bermejo JL, Planelles D, Requena C, Hemminki K, Nagore E, Kumar R.

BMC Cancer. 2013 Jul 2;13:325. doi: 10.1186/1471-2407-13-325.

8.

IRF4 SNP is predictive of melanoma subtypes.

Granovetter M.

Lancet Oncol. 2016 Mar;17(3):e96. doi: 10.1016/S1470-2045(16)00113-3. Epub 2016 Feb 18. No abstract available.

PMID:
26907189
9.

[Melanoma of human skin: its epidemiology, etiology and pathogenesis].

Korovin SI.

Lik Sprava. 1998 Jun;(4):46-50. Review. Russian. No abstract available.

PMID:
9784700
11.

Genetic epidemiology of cutaneous melanoma: a global perspective.

Goldstein AM, Tucker MA.

Arch Dermatol. 2001 Nov;137(11):1493-6. Review. No abstract available.

PMID:
11708953
12.

Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure.

Matichard E, Verpillat P, Meziani R, Gérard B, Descamps V, Legroux E, Burnouf M, Bertrand G, Bouscarat F, Archimbaud A, Picard C, Ollivaud L, Basset-Seguin N, Kerob D, Lanternier G, Lebbe C, Crickx B, Grandchamp B, Soufir N.

J Med Genet. 2004 Feb;41(2):e13. No abstract available.

13.

Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk.

Liu H, Wang LE, Liu Z, Chen WV, Amos CI, Lee JE; Q-MEGA and AMFS Investigators; GenoMEL Investigators, Iles MM, Law MH, Barrett JH, Montgomery GW, Taylor JC, MacGregor S, Cust AE, Newton Bishop JA, Hayward NK, Bishop DT, Mann GJ, Affleck P, Wei Q.

Carcinogenesis. 2013 Apr;34(4):885-92. doi: 10.1093/carcin/bgs407. Epub 2013 Jan 4.

14.

Melanoma susceptibility and progression: Association study between polymorphisms of the chemokine (CCL2) and chemokine receptors (CX3CR1, CCR5).

Rodero M, Rodero P, Descamps V, Lebbe C, Wolkenstein P, Aegerter P, Vitoux D, Basset-Seguin N, Dupin N, Grandchamp B, Soufir N, Combadière C, Saiag P; Melan-cohort investigators.

J Dermatol Sci. 2007 Apr;46(1):72-6. Epub 2006 Dec 13. No abstract available.

PMID:
17169533
15.

Prediction of Melanoma Risk in a Southern European Population Based on a Weighted Genetic Risk Score.

Kypreou KP, Stefanaki I, Antonopoulou K, Karagianni F, Ntritsos G, Zaras A, Nikolaou V, Kalfa I, Chasapi V, Polydorou D, Gogas H, Spyrou GM, Bertram L, Lill CM, Ioannidis JP, Antoniou C, Evangelou E, Stratigos AI.

J Invest Dermatol. 2016 Mar;136(3):690-5. doi: 10.1016/j.jid.2015.12.007. Epub 2015 Dec 14.

16.

Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls.

Casula M, Alaibac M, Pizzichetta MA, Bono R, Ascierto PA, Stanganelli I, Canzanella S, Palomba G, Zattra E; Italian Melanoma Intergroup (IMI), Palmieri G.

BMC Dermatol. 2009 Jul 22;9:7. doi: 10.1186/1471-5945-9-7.

17.

A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.

Han J, Qureshi AA, Nan H, Zhang J, Song Y, Guo Q, Hunter DJ.

Cancer Res. 2011 Mar 1;71(5):1533-9. doi: 10.1158/0008-5472.CAN-10-1818. Epub 2011 Jan 26.

18.

Inherited genetic variants associated with occurrence of multiple primary melanoma.

Gibbs DC, Orlow I, Kanetsky PA, Luo L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Sharma A, La Pilla E, From L, Busam KJ, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):992-7. doi: 10.1158/1055-9965.EPI-14-1426. Epub 2015 Apr 2.

19.

Replication of genetic loci for ages at menarche and menopause in the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) study.

Carty CL, Spencer KL, Setiawan VW, Fernandez-Rhodes L, Malinowski J, Buyske S, Young A, Jorgensen NW, Cheng I, Carlson CS, Brown-Gentry K, Goodloe R, Park A, Parikh NI, Henderson B, Le Marchand L, Wactawski-Wende J, Fornage M, Matise TC, Hindorff LA, Arnold AM, Haiman CA, Franceschini N, Peters U, Crawford DC.

Hum Reprod. 2013 Jun;28(6):1695-706. doi: 10.1093/humrep/det071. Epub 2013 Mar 18.

20.

Identification of a melanoma susceptibility locus and somatic mutation in TET2.

Song F, Amos CI, Lee JE, Lian CG, Fang S, Liu H, MacGregor S, Iles MM, Law MH, Lindeman NI, Montgomery GW, Duffy DL, Cust AE, Jenkins MA, Whiteman DC, Kefford RF, Giles GG, Armstrong BK, Aitken JF, Hopper JL, Brown KM, Martin NG, Mann GJ, Bishop DT, Bishop JA; GenoMEL consortium, Kraft P, Qureshi AA, Kanetsky PA, Hayward NK, Hunter DJ, Wei Q, Han J.

Carcinogenesis. 2014 Sep;35(9):2097-101. doi: 10.1093/carcin/bgu140. Epub 2014 Jun 30.

Supplemental Content

Support Center